Sponsor Showcase

Millipore

About MilliporeSigma

The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.

Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.

Merck KGaA, Darmstadt, Germany is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials – and generated sales of €12.85 billion in 2015. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.

Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. The company holds the global rights to the name and the trademark “Merck” internationally except for the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Millipore

EMD Millipore Headquarters
 290 Concord Road
Billerica, Massachusetts 01821
United States of America
1-800-MILLIPORE (+1 800-645-5476)
Websites
www.sigmaaldrich.com/united-states.html
www.emdmillipore.com/
www.emdgroup.com/emd/index.html

At MilliporeSigma, it’s our mission to help scientists solve some of the toughest problems in Life Science research. We understand that as a provider of antibody reagents, tools that are used every day to advance scientific research, we play an important role in that effort. We believe that the robust performance and consistency of our antibodies can make a critical difference in this cause.

Our commitment to produce quality antibodies is rooted in our focus on the customer and their application-specific needs. This collaborative approach not only helps us rapidly provide new antibodies that our customers want, but it has also helped us understand the standard of application testing and information that’s needed and the level of technical service resources required to support optimal product usage and performance.

As a long standing manufacturer and developer of antibodies, this approach has led us to being first to market with antibody reagents that were rapidly adopted and are still iconic in the areas of Neuroscience, Cancer, and Epigenetics research. But it has also enabled us to provide advanced antibody assays based on highly characterized and validated multiplex panels and entirely new levels of cell characterization through our imaging flow cytometry platforms.

But as every antibody and experimental design is unique, individual assays designed by customers themselves must still be optimized empirically. And this often includes careful consideration of antibody titers, samples sources, and the design of experiment.

Because we recognize these challenges, our antibodies are also backed by the support of a highly trained technical staff that can provide guidance in individual experimental design and usage. This includes step by step assistance in techniques and troubleshooting based on many years of experience. So at MilliporeSigma we take our role in the mission to help scientists solve the toughest problems in Life Science research very seriously, and we recognize it is our partnership with scientists that make the biggest difference.